In vitro bactericidal and anticancer activity of new metabolite, ARK42, isolated from Aspergillus repens K42

Je Won Park, Beom Seok Song, Dojin Ryu, Chan Lee, Young Bae Kim

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

A novel antibacteria metabolite, ARK42, was isolated from a xerophilic fungal strain K42, and identified as Aspergillus repens based on its morphological characteristics. The metabolite exhibited antibacterial activities towards Staphylococcus aureus, Bacillus cereus, and Pseudomonas aeruginosa, with MICs of 25, 12.5, and 3.125 μg/ml, respectively, and killed Pseudomonas aeruginosa with minimal bactericidal concentration (MBC) of 12.5 μg/ml. Furthermore, anticancer activities were demonstrated against human colon cancer DLD-1 and lung cancer LXFL529 cells with an IC50 of 10 and 1 μg/ml, respectively.

Original languageEnglish
Pages (from-to)1017-1021
Number of pages5
JournalJournal of microbiology and biotechnology
Volume12
Issue number6
Publication statusPublished - 2002 Dec 1

Fingerprint

Aspergillus
Pseudomonas aeruginosa
Bacillus cereus
Colonic Neoplasms
Inhibitory Concentration 50
Staphylococcus aureus
Lung Neoplasms
In Vitro Techniques

Keywords

  • Anticancer activity
  • Aspergillus repens
  • Bactericidal activity

ASJC Scopus subject areas

  • Biotechnology
  • Applied Microbiology and Biotechnology

Cite this

In vitro bactericidal and anticancer activity of new metabolite, ARK42, isolated from Aspergillus repens K42. / Park, Je Won; Song, Beom Seok; Ryu, Dojin; Lee, Chan; Kim, Young Bae.

In: Journal of microbiology and biotechnology, Vol. 12, No. 6, 01.12.2002, p. 1017-1021.

Research output: Contribution to journalArticle

Park, Je Won ; Song, Beom Seok ; Ryu, Dojin ; Lee, Chan ; Kim, Young Bae. / In vitro bactericidal and anticancer activity of new metabolite, ARK42, isolated from Aspergillus repens K42. In: Journal of microbiology and biotechnology. 2002 ; Vol. 12, No. 6. pp. 1017-1021.
@article{0ea798bb1e834daba56161f27b40de33,
title = "In vitro bactericidal and anticancer activity of new metabolite, ARK42, isolated from Aspergillus repens K42",
abstract = "A novel antibacteria metabolite, ARK42, was isolated from a xerophilic fungal strain K42, and identified as Aspergillus repens based on its morphological characteristics. The metabolite exhibited antibacterial activities towards Staphylococcus aureus, Bacillus cereus, and Pseudomonas aeruginosa, with MICs of 25, 12.5, and 3.125 μg/ml, respectively, and killed Pseudomonas aeruginosa with minimal bactericidal concentration (MBC) of 12.5 μg/ml. Furthermore, anticancer activities were demonstrated against human colon cancer DLD-1 and lung cancer LXFL529 cells with an IC50 of 10 and 1 μg/ml, respectively.",
keywords = "Anticancer activity, Aspergillus repens, Bactericidal activity",
author = "Park, {Je Won} and Song, {Beom Seok} and Dojin Ryu and Chan Lee and Kim, {Young Bae}",
year = "2002",
month = "12",
day = "1",
language = "English",
volume = "12",
pages = "1017--1021",
journal = "Journal of Microbiology and Biotechnology",
issn = "1017-7825",
publisher = "Korean Society for Microbiolog and Biotechnology",
number = "6",

}

TY - JOUR

T1 - In vitro bactericidal and anticancer activity of new metabolite, ARK42, isolated from Aspergillus repens K42

AU - Park, Je Won

AU - Song, Beom Seok

AU - Ryu, Dojin

AU - Lee, Chan

AU - Kim, Young Bae

PY - 2002/12/1

Y1 - 2002/12/1

N2 - A novel antibacteria metabolite, ARK42, was isolated from a xerophilic fungal strain K42, and identified as Aspergillus repens based on its morphological characteristics. The metabolite exhibited antibacterial activities towards Staphylococcus aureus, Bacillus cereus, and Pseudomonas aeruginosa, with MICs of 25, 12.5, and 3.125 μg/ml, respectively, and killed Pseudomonas aeruginosa with minimal bactericidal concentration (MBC) of 12.5 μg/ml. Furthermore, anticancer activities were demonstrated against human colon cancer DLD-1 and lung cancer LXFL529 cells with an IC50 of 10 and 1 μg/ml, respectively.

AB - A novel antibacteria metabolite, ARK42, was isolated from a xerophilic fungal strain K42, and identified as Aspergillus repens based on its morphological characteristics. The metabolite exhibited antibacterial activities towards Staphylococcus aureus, Bacillus cereus, and Pseudomonas aeruginosa, with MICs of 25, 12.5, and 3.125 μg/ml, respectively, and killed Pseudomonas aeruginosa with minimal bactericidal concentration (MBC) of 12.5 μg/ml. Furthermore, anticancer activities were demonstrated against human colon cancer DLD-1 and lung cancer LXFL529 cells with an IC50 of 10 and 1 μg/ml, respectively.

KW - Anticancer activity

KW - Aspergillus repens

KW - Bactericidal activity

UR - http://www.scopus.com/inward/record.url?scp=0037001090&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037001090&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0037001090

VL - 12

SP - 1017

EP - 1021

JO - Journal of Microbiology and Biotechnology

JF - Journal of Microbiology and Biotechnology

SN - 1017-7825

IS - 6

ER -